[1] Allergan,Neugen Pharma, Inc.
[2] Eli Lilly & Company,Laboratory for Structure and Function Research
[3] Duke University,Department of Molecular Neuroscience
[4] Georgetown University Medical Center,Epilepsy Research Section
[5] The Institute of Medical Sciences,Department of Neurology
[6] Tokai University,Department of Psychiatry
[7] The Institute of Medical Sciences,Department of Psychiatry
[8] Tokai University,National Institute of Neurological Disorders and Stroke
[9] The Institute of Medical Sciences,undefined
[10] Tokai University,undefined
[11] Regeneron Pharmaceuticals,undefined
[12] Queens College of CUNY,undefined
[13] Neuropsychology and Neuroscience,undefined
[14] Graduate Center of CUNY,undefined
[15] NINDS,undefined
[16] NIH,undefined
[17] Research Triangle Institute,undefined
[18] University of Messina,undefined
[19] University of California,undefined
[20] Davis,undefined
[21] KAI Research,undefined
[22] Inc.,undefined
[23] Children’s National Medical Center,undefined
[24] Georgetown University,undefined
[25] Urea Cycle Rare Disorders Consortium,undefined
[26] University of Rochester Medical Center,undefined
[27] University of South Florida College of Medicine,undefined
[28] FLENl-Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia,undefined
[29] Lowenstein Rehabilitation Hospital,undefined
[30] NeuroHealing Pharmaceuticals,undefined
[31] University of Missouri-Columbia,undefined
[32] Medical University of South Carolina,undefined
[33] Parkinson’s Disease Foundation,undefined
[34] University of Iowa,undefined
[35] University of Western Australia,undefined
[36] National Institutes of Health,undefined
